4.32

1.41% 0.06

After Hours: 4.32

Outset Medical Inc (OM)

Overview News Price History Option Chain Financials Why OM Down? Discussions Forecast

Outset Medical Inc stock is traded at $4.32, with a volume of 103.43K. It is up +1.41% in the last 24 hours and down -4.42% over the past month. Outset Medical Inc is a medical technology company pioneering a technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.

Previous Close:

$4.26

Open:

$4.3

24h Volume:

103.43K

Relative Volume:

0.59

Market Cap:

$80.08M

Revenue:

$117.59M

Net Income/Loss:

$-74.85M

P/E Ratio:

-1.0347

EPS:

-4.175

Net Cash Flow:

$-34.25M

1W Performance:

+19.01%

1M Performance:

-4.42%

6M Performance:

+0.70%

1Y Performance:

-76.61%

1-Day Range:

$4.11

$4.4499

1-Week Range:

$3.574

$4.4499

52-Week Range:

$3.00

$21.98

Outset Medical Inc Stock (OM) Company Profile

Name

Outset Medical Inc

Sector

Healthcare (1108)

Industry

Medical Devices (143)

Phone

669-231-8200

Address

3052 ORCHARD DRIVE, SAN JOSE

Employee

310

Twitter

Next Earnings Date

2026-05-07

Latest SEC Filings

OM's Discussions on Twitter

Compare OM vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
OM Outset Medical Inc	4.32	78.97M	117.59M	-74.85M	-34.25M	-4.175
ABT Abbott Laboratories	87.41	152.88B	45.13B	6.28B	7.38B	3.5895
SYK Stryker Corp	316.48	120.18B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	78.60	100.34B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	57.78	84.95B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	85.78	47.91B	6.30B	1.07B	1.09B	1.8406

Outset Medical Inc Stock (OM) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-08-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Jun-21-24	Upgrade	RBC Capital Mkts	Sector Perform → Outperform
Apr-08-24	Initiated	BTIG Research	Buy
Apr-05-24	Upgrade	CL King	Neutral → Buy
Jan-12-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Oct-13-23	Downgrade	BofA Securities	Buy → Underperform
Aug-17-23	Initiated	CL King	Neutral
Nov-11-22	Initiated	RBC Capital Mkts	Outperform
Jul-14-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Mar-02-22	Resumed	BofA Securities	Buy
Feb-17-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Aug-18-21	Initiated	Cowen	Outperform
Apr-19-21	Initiated	Wells Fargo	Overweight
Dec-16-20	Initiated	Oppenheimer	Perform
Oct-12-20	Initiated	Barclays	Overweight
Oct-12-20	Initiated	BofA Securities	Buy
Oct-12-20	Initiated	Goldman	Buy
Oct-12-20	Initiated	Morgan Stanley	Equal-Weight
Oct-12-20	Initiated	SVB Leerink	Mkt Perform
Oct-12-20	Initiated	Stifel	Buy

View All

Outset Medical Inc Stock (OM) Latest News

May 21, 2026

Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

May 21, 2026

May 20, 2026

Outset Medical (OM) Price Target Decreased by 38.83% to 16.06 - MSN

May 20, 2026

Outset Medical: General counsel Brottem sells $9,760 in shares - Investing.com India

May 20, 2026

Outset Medical CEO Leslie Trigg sells $12,746 in OM shares - Investing.com India

May 20, 2026

May 19, 2026

Outset Medical EVP Marc Nash sells $5,853 in common stock - Investing.com India

May 19, 2026

Outset Medical EVP Marc Nash sells $5,853 in common stock By Investing.com - Investing.com South Africa

May 19, 2026

Outset Medical: General counsel Brottem sells $9,760 in shares By Investing.com - Investing.com South Africa

May 19, 2026

Outset Medical CEO Leslie Trigg sells $12,746 in OM shares By Investing.com - Investing.com Nigeria

May 19, 2026

Outset Medical (OM) EVP sells 1,582 shares in tax-related ‘sell to cover’ - Stock Titan

May 19, 2026

May 18, 2026

BML Investment Partners takes 13.6% stake in Outset Medical (OM) - Stock Titan

May 18, 2026

Outset Medical (OM) major holder assigned 323K shares via June 2026 puts - Stock Titan

May 18, 2026

May 16, 2026

Outset Medical (OM) price target decreased by 14.81% to 7.82 - MSN

May 16, 2026

May 15, 2026

OM (NASDAQ: OM) settles 4,277 RSUs; Marc Nash sold 1,830 shares earlier - Stock Titan

May 15, 2026

OM (NASDAQ: OM) files Form 144 for 9,319 RSU settlement on 05/15/2026 - Stock Titan

May 15, 2026

OM (NASDAQ) director files Form 144 reporting 5,033 RSUs settled and prior sale - Stock Titan

May 15, 2026

Outset Medical (OM) amendment shows no beneficial ownership by Alyeska entities - Stock Titan

May 15, 2026

Here’s Why Outset Medical (OM) Rebound Sharply After Last Quarter’s Selloff - Insider Monkey

May 13, 2026

May 12, 2026

BML Investment Partners files 13G/A reporting 11.8% stake in Outset Medical (OM) - Stock Titan

May 12, 2026

Outset Medical (OM) 10% holder entities exercise derivatives to acquire over 294K shares - Stock Titan

May 12, 2026

May 11, 2026

Outset Medical to Present at RBC Global Healthcare Conference - The Manila Times

May 11, 2026

Dialysis tech firm Outset Medical to speak at RBC health conference - Stock Titan

May 11, 2026

Outset Medical net revenue drops 6% to USD 27.9M in Q1 2026 - Medical Buyer

May 11, 2026